Redeye strengthens its positive view of Formpipe following the solid Q4 report showing a record-high ACV. We feel more confident that the margins will improve during 2023 and raise our Base Case and forecasts slightly.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/